Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Uncategorized

Morgan Stanley Downgrades Haemonetics to Equal-Weight, Lowers Price Target to $83

Morgan Stanley analyst Drew Ranieri downgrades Haemonetics (NYSE:HAE) from Overweight to Equal-Weight and lowers the price target from $147 to $83.
byBenzinga Newsdesk
April 20, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Morgan Stanley analyst Drew Ranieri downgrades Haemonetics (NYSE:HAE) from Overweight to Equal-Weight and lowers the price target from $147 to $83.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More
Uncategorized

Economic Data Scheduled For Monday

By Lisa Levin
Today, 3:16 AM
The Treasury is set to auction 3-month bills at 11:30 a.m. ET. The Treasury will also auction 6-month bills at 11:30 a.m. ET. Check out the full economic calendar here